series-b
Stage
1
Investors
About
Zeroshot develops AI-driven learning pipelines that analyze zebrafish drug exposure data combined with single-cell RNA sequencing to generate human pre-clinical insights, helping therapeutics developers optimize compound rankings and accelerate hit-to-lead decisions.
Explore Zeroshot's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.